Chemoinformaics analysis of 1,3,6,8-Tetranitro-4,5-Dihydroxy-2-Hydroxymethylanthraquinones
| Molecular Weight | 450.228 | nRot | 5 |
| Heavy Atom Molecular Weight | 444.18 | nRig | 24 |
| Exact Molecular Weight | 449.993 | nRing | 3 |
| Solubility: LogS | -4.879 | nHRing | 0 |
| Solubility: LogP | -1.91 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 2 |
| nHetero | 17 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 6 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 4 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 13 | No. of Arom Bond | 12 |
| nHA | 13 | APOL | 43.8768 |
| nHD | 3 | BPOL | 12.4192 |
| QED | 0.096 |
| Synth | 5.15 |
| Natural Product Likeliness | 0.1 |
| NR-PPAR-gamma | 0 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.999 |
| HIA | 0.628 |
| CACO-2 | -5.667 |
| MDCK | 0.00226383 |
| BBB | 0.025 |
| PPB | 0.733898 |
| VDSS | 1.041 |
| FU | 0.184814 |
| CYP1A2-inh | 0.362 |
| CYP1A2-sub | 0.023 |
| CYP2c19-inh | 0.019 |
| CYP2c19-sub | 0.028 |
| CYP2c9-inh | 0.172 |
| CYP2c9-sub | 0.261 |
| CYP2d6-inh | 0 |
| CYP2d6-sub | 0.016 |
| CYP3a4-inh | 0.008 |
| CYP3a4-sub | 0 |
| CL | 1.958 |
| T12 | 0.216 |
| hERG | 0.163 |
| Ames | 0.572 |
| ROA | 0.071 |
| SkinSen | 0.96 |
| Carcinogencity | 0.173 |
| EI | 0.863 |
| Respiratory | 0.308 |
| NR-Aromatase | 0 |
| Antiviral | No |
| Prediction | 0.518901 |